Literature DB >> 33992041

Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients

Muhammet Dural1, Göknur Yorulmaz2, Elif Sevil Alagüney3, Kadir Uğur Mert1, Ezgi Çamli1, Ahmet Toygar Kalkan2, Aysen Akalin2, Nur Kebapçi2, Ahmet Serdar Yilmaz1, Selda Murat1, Belgin Efe2.   

Abstract

Background/aim: It is known that the presence of fragmented QRS (fQRS) on electrocardiography (ECG) is associated with cardiovascular events. The aim of this study was the evaluation of fQRS formation and its relationship with the left ventricular hypertrophy (LVH) parameters in acromegaly patients. Materials and methods: In total, 47 previously diagnosed with non-hypertensive acromegaly patients and 48 control subjects were included in the study. ECG and transthoracic echocardiography (TTE) were performed for each participant. Acromegaly patients were divided into two groups according to the fQRS formation on the ECG. Left ventricular wall thicknesses, and left atrial diameter (LAD), left ventricular mass (LVM), left ventricular mass index (LVMi), and relative wall thickness (RWT) were obtained.
Results: In control group 5 (10.4%) and in acromegaly group 17 (36.2%) patients had fQRS on ECG (p = 0.003). LAD [36.0 (34.0–38.0) vs. 38.0 (35.0–41.0) mm, p < 0.001], LVM [155.27 ± 27.00 vs. 173.0 (153.0–235.0) g, p < 0.001], LVMi [83.12 ± 13.19 vs. 92.0 (83.0–118.0) g/m², p < 0.001] and RWT [0.39 ± 0.03 vs. 0.43 (0.41–0.45), p = 0.001] were significantly higher in patients with acromegaly. Disease duration was significantly higher (11.59 ± 1.3 vs. 8.2 ± 1.8 years, p < 0.001) in the fQRS (+) group. LAD [41.0 (39.0–42.5) vs. 37.0 (34.7–38.0) mm, p < 0.001], LVM [219.0 (160.5–254.5) vs. 164.0 (153.0–188.0) g, p = 0.017], LVMi [117.0 (92.5–128.5) vs. 86.0 (82.0–100.2) g/m², p = 0.013] and RWT [0.44 (0.42–0.49) vs. 0.43 (0.40–0.44), p = 0.037] were significantly higher in fQSR (+) acromegaly patients. In multivariate logistic regression analysis, disease duration (odds ratio: 10.05, 95% CI: 1.099–92.012, p = 0.041) and LAD (odds ratio: 2.19, 95% CI: 1.030–4.660, p = 0.042) were found to be the independent predictors of fQRS formation.
Conclusion: The results of our study revealed that fQRS (+) acromegaly patients had increased LVH parameters compared to fQRS (-) patients. This work is licensed under a Creative Commons Attribution 4.0 International License.

Entities:  

Keywords:  Acromegaly; fragmented QRS; left ventricular hypertrophy; left ventricular mass

Mesh:

Year:  2021        PMID: 33992041      PMCID: PMC8742487          DOI: 10.3906/sag-2101-229

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  40 in total

1.  LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.

Authors:  Khiet Hoang; Yanglu Zhao; Julius M Gardin; Mercedes Carnethon; Ken Mukamal; David Yanez; Nathan D Wong
Journal:  JACC Cardiovasc Imaging       Date:  2015-08-26

Review 2.  Acromegalic Cardiomyopathy: An Overview of Risk Factors, Clinical Manifestations, and Therapeutic Options.

Authors:  Michael D Goldberg; Natasha Vadera; Srikanth Yandrapalli; William H Frishman
Journal:  Cardiol Rev       Date:  2018 Nov/Dec       Impact factor: 2.644

3.  Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?

Authors:  R López-Velasco; H F Escobar-Morreale; B Vega; E Villa; J M Sancho; J L Moya-Mur; R García-Robles
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

4.  Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.

Authors:  Annamaria Colao; Rosario Pivonello; Ludovica Francesca Stella Grasso; Renata Simona Auriemma; Mariano Galdiero; Silvia Savastano; Gaetano Lombardi
Journal:  Eur J Endocrinol       Date:  2011-08-25       Impact factor: 6.664

5.  Relationship between serum bilirubin levels and presence of fragmented QRS in patients with acute coronary syndrome.

Authors:  Muhammet Dural; Hamza Sunman; Engin Algül; Hüdaverdi Hocamguliyev; Haluk Furkan Şahan; Tolga Çimen; Sadık Açıkel; Murat Tulmaç
Journal:  Biomark Med       Date:  2019-11-15       Impact factor: 2.851

6.  Relationship between fragmented QRS and no-reflow, infarct size, and peri-infarct zone assessed using cardiac magnetic resonance in patients with myocardial infarction.

Authors:  Luc Lorgis; Alexandre Cochet; Olivier Chevallier; Marion Angue; Aurelie Gudjoncik; Alain Lalande; Marianne Zeller; Philippe Buffet; François Brunotte; Yves Cottin
Journal:  Can J Cardiol       Date:  2013-12-04       Impact factor: 5.223

Review 7.  Growth hormone, acromegaly, and heart failure: an intricate triangulation.

Authors:  Luigi Saccà; Raffaele Napoli; Antonio Cittadini
Journal:  Clin Endocrinol (Oxf)       Date:  2003-12       Impact factor: 3.478

8.  Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction.

Authors:  Ning Zhu; Hao Chen; Xuyong Zhao; Fanhao Ye; Wenbing Jiang; Yi Wang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 9.  A Consensus Statement on acromegaly therapeutic outcomes.

Authors:  Shlomo Melmed; Marcello D Bronstein; Philippe Chanson; Anne Klibanski; Felipe F Casanueva; John A H Wass; Christian J Strasburger; Anton Luger; David R Clemmons; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

10.  Cardiovascular System Changes and Related Risk Factors in Acromegaly Patients: A Case-Control Study.

Authors:  Xiaopeng Guo; Lu Gao; Shuo Zhang; Yilin Li; Yue Wu; Ligang Fang; Kan Deng; Yong Yao; Wei Lian; Renzhi Wang; Bing Xing
Journal:  Int J Endocrinol       Date:  2015-10-27       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.